Category
Video: Practical Strategies for Emerging, Small, and Mid-Size Companies
In the recently held Medicaid Drug Rebate Program (MDRP) Conference, a session titled Practical Strategies for Emerging, Small, and Mid-Size Companies offered essential insights for pharmaceutical companies navigating the complexities of expansion, commercialization, and mergers & acquisitions. The session, led by RLDatix Life Sciences’ Katie Johnson, Senior Director of Revenue… Read More
5 Stats to Watch in State Price Transparency
In Life Sciences, price transparency is a basic regulatory requirement. It’s also a strategic imperative that influences market access, patient affordability, and company reputation. Across the United States, state-specific regulations play a pivotal role in shaping how price transparency is implemented and governed. These regulations are designed to ensure that… Read More
7 Tips for Managing Multi-State Drug Pricing Compliance in Life Sciences
Navigating the regulatory landscape of multi-state pricing compliance in the Life Sciences sector can be challenging. With different states enforcing varying regulations on drug pricing and transparency, companies need a robust strategy to ensure compliance and mitigate risks. Here are seven practical tips to help manage multi-state pricing compliance effectively. Read More